Showing results (21-30 of 248) with videos related to
Sort By:
Pageof 25
Cancers|November 9, 2013
Immune-checkpoint blockade and active immunotherapy for gliomaBrian J Ahn, Ian F Pollack, Hideho OkadaPlos One|May 14, 2013
In vivo intracellular oxygen dynamics in murine brain glioma and immunotherapeutic response of cytotoxic T cells observed by fluorine-19 magnetic resonance imagingJia Zhong, Masashi Sakaki, Hideho Okada, et al.Journal of Neuro-Oncology|December 1, 2010
Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapyXinmei Zhu, Mitsugu Fujita, Linda A Snyder, et al.Cancers|July 29, 2023
Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade GliomaMarco Gallus, Darwin Kwok, Senthilnath Lakshmanachetty, et al.European Journal of Immunology|October 30, 2008
IL-4 inhibits VLA-4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefitKotaro Sasaki, Angela D Pardee, Hideho Okada, et al.Biochemical and Biophysical Research Communications|February 14, 2015
Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activityAkemi Kosaka, Takayuki Ohkuri, Maki Ikeura, et al.Cancers|January 11, 2024
Correction: Gallus et al. Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma. Cancers 2023, 15, 3726Marco Gallus, Darwin Kwok, Senthilnath Lakshmanachetty, et al.Current Oncology Reports|January 26, 2021
Current Advances in Immunotherapy for GlioblastomaAbigail L Mende, Jessica D Schulte, Hideho Okada, et al.Journal for Immunotherapy of Cancer|July 1, 2021
IFN-γ- and IL-17-producing CD8+ T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activityTakayuki Ohkuri, Akemi Kosaka, Maki Ikeura, et al.Annals of the New York Academy of Sciences|May 9, 2013
Integration of epidemiology, immunobiology, and translational research for brain tumorsHideho Okada, Michael E Scheurer, Saumendra N Sarkar, et al.Pageof 25